[S(R)]-N-[(S)-(3,5-双叔丁基-4-甲氧基苯基)[2-(二苯基膦)苯基]甲基]-N-甲基-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(S)-[3,5-Bis(1,1-dimethylethyl)-4-methoxyphenyl][2-(diphenylphosphino)phenyl]methyl]-N,2-dimethyl-2-propanesulfinamide

（4S）-4-i-丙基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯

(S)-3-Boc-4-isopropyl-2,2-dioxo-[1,2,3]oxathiazolidine

≥98%

羟基乙叉二膦酸水合物, 96%

Etidronic acid (HEDP) hydrate

(1S)-[(2R)-2-二环己基膦基二茂铁基](N,N-二甲基氨基)(2-二环己基膦基苯基)甲烷, 99%

(1S)-1-(Dicyclohexylphosphino)-2-[(R)-[2-(dicyclohexylphosphino)phenyl](dimethylamino)methyl]ferrocene

[S(R)]-N-[(S)-(4-叔丁基苯基)[5-(二苯基膦)-9,9-二甲基-9H-氧杂蒽]甲基]-N-甲基-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(S)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-N,2-dimethyl-2-propanesulfinamide

（4S）-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯

(S)-3-Boc-4-tert-butyl-2,2-dioxo-[1,2,3]oxathiazolidine

≥98%

(8α,9S)-6'-甲氧基辛可宁-9-胺三盐酸盐, 98%

(8α,9S)-6'-Methoxycinchonan-9-amine trihydrochloride

(1S,2R)-2-氨基环戊醇盐酸盐, 99%

(1S,2R)-2-Aminocyclopentanol hydrochloride

[S(R)]-N-[(S)-(4-甲氧基苯基)[2-(二叔丁基膦)苯基]甲基]-N-甲基-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(S)-(4-Methoxyphenyl)[2-(di-tert-butylphosphino)phenyl]methyl]-N,2-dimethyl-2-propanesulfinamide

(2S,3S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2-(2-甲氧基丙烷-2-基)-2,3-二氢苯并[D][1,3]氧膦杂环

(2S,3S)-3-(Tert-butyl)-4-(2,6-dimethoxyphenyl)-2-(2-methoxypropan-2-yl)-2,3-dihydrobenzo[d][1,3]oxaphosphole

98%，99.9% ee

(R)-4-苯基丁烷-2-醇, 98%

(R)-(-)-4-Phenyl-2-butanol

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

GSK-3抑制剂XIII

GSK-3 Inhibitor XIII

99%

[S(R)]-N-[(S)-1-[5-(二苯基膦)-9,9-二甲基-9H-氧杂蒽]乙基]-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(S)-1-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]ethyl]-2-methyl-2-propanesulfinamide

1-{(1S,2R)-1-[(11bR)-2,6-二甲基二萘酚[2,1-d:1',2'-f][1,3,2]二氧磷杂七-4-基氧基]-1-苯基丙-2-基}-3-苯基脲

1-{(1S,2R)-1-[(11bR)-2,6-Dimethyldinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]-1-phenylpropan-2-yl}-3-phenylurea

98%

(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基恶唑], 99%，ee99.9%

(4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole]

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

[S(R)]-N-[(S)-2-(二环己基膦)苯基]-1-萘基甲基]-2-叔丁基亚磺酰胺, 98%

[S(R)]-N-[(S)-[2-(Dicyclohexylphosphino)phenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide

[S(R)]-N-[(1R)-1-[2-(二叔丁基膦)苯基]苯甲基]-2-叔丁基亚磺酰胺, ≥98%

[S(R)]-N-[(1R)-1-[2-(Di-tert-butylphosphanyl)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide

1-{2S）-1-[（11bR）-2,6-双（三甲基甲硅烷基）二萘并[2,1-d：1''，2''-f] [1,3,2]二氧杂磷-4-氧基]丙烷-2-基}-3-苯基脲

1-{2S)-1-[(11bR)-2,6-Bis(trimethylsilyl)dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin-4-yloxy]propan-2-yl}-3-phenylurea

98%